Pulmonary Rehabilitation for people living with Post-TB lung disease in Kyrgyzstan: Global RECHARGE Kyrgyzstan

niversity of Leicester0 个研究点目标入组 114 人开始时间: 2019年9月12日最近更新: 2023年10月23日

适应症

试验速览

2022 Interim results article in https://pubmed.ncbi.nlm.nih.gov/35121602/ Qualitative results (added 07/02/2022) 2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35190411/ (added 23/02/2022)

•Stage 1 (patient):
•1. Aged =18 years
•2. Physician diagnosis of COPD
•Stage 1 (staff):
•1. Healthcare staff that would typically refer patients to a clinical PR programme, such as physicians & clinicians.
•1. Aged =18 years;
•2. Definite diagnosis of a TB-negative patients with PTBLD lung disease
•3. Previous TB treatment or finished treatment
•4. Medical Research Council dyspnoea score grade 2 or higher

•Stage 1 (patients):
•1. Unable or unwilling to provide informed consent
•Stage 2 (staff):
•1. Unable or unwilling to provide informed consent
•1. Comorbidities such as severe or unstable cardiovascular, other internal diseases and locomotor difficulties that preclude exercise
•2. Malignant disease such as lung cancer
•3. Evidence of active TB on Chest X-ray or sputum tests within 1 month of assessment
•4. Unable or unwilling to provide informed consent.

发起方

niversity of Leicester